Biofusion launches Genophrenix
Second new spin-out company to focus on developing targets and compounds to treat schizophrenia
27-Feb-2006 -
Biofusion plc announced the creation of Genophrenix Limited, a new spin-out company from its pipeline agreement with the University of Sheffield. Genophrenix has been formed to capitalise on the discovery of specific proteins that are involved with a key biochemical pathway implicated in a range ...
diseases
proteins
schizophrenia